Taking Gene Editing by Storm Friday, March 04, 2016 Gene Editing – the ability to remove or replace genes in living organisms – has been a leading driver in molecular biology. The recent emergence of CRISPR/Cas9 significantly lowers the workflow and expertise barrier. Rare Disease or Rare Success: A Tale of Two Genomes Friday, March 04, 2016 Congenica to help woman who self-diagnosed the genetic cause of both her muscle wasting disease and an Olympic athlete’s extreme muscular physique.Chi-Med Initiates Sulfatinib Phase II Clinical Trial in Thyroid Cancer Thursday, March 03, 2016 Company has initiated an open-label Phase II clinical trial to evaluate the efficacy and safety of sulfatinib (HMPL-012) in patients with differentiated thyroid cancer (“DTC”) or medullary thyroid cancer (“MTC”).Gene Identified that Helps Wound Healing Thursday, March 03, 2016 New research from Ohio State University on gene that regulates healing and may control scarring to be presented at the annual meeting of the Biophysical Society this week in Los Angeles.Forensic Botany Uses Plant DNA to Trace Crimes Thursday, March 03, 2016 Sam Houston State University is advancing the field of forensic botany with the publication of two recent studies that use marijuana DNA to link drug supplies and pollen DNA to aid in forensic investigations.First Gene for Grey Hair Found Thursday, March 03, 2016 The first gene identified for greying hair has been discovered by an international UCL-led study, confirming greying has a genetic component and is not just environmental. - See more at: https://www.ucl.ac.uk/news/news-articles/0316/010316-first-grey-hair-gene-discovered#sthash.gD0shNNC.dpufBiomarker Identifies Eye Cancer Patients at High Risk for Metastasis Wednesday, March 02, 2016 A study by J. William Harbour, M.D., Associate Director for Basic Research and leader of the Eye Cancer Site Disease Group at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and colleagues details the discovery of a biomarker that puts patients at a higher risk for metastasis of uveal melanoma.SomaLogic Raises up to $60.5M Wednesday, March 02, 2016 SomaLogic, Inc., and Visium Healthcare Partners, LP has announced that SomaLogic will receive up to $60.5 million through a combination of debt and equity financing from Visium. Gene Therapy for Parkinson’s Disease to be Tested by Pitt, UPMC Experts Tuesday, March 01, 2016 Experts at the University of Pittsburgh have used gene therapy to relieve the symptoms of tremor and mobility impairment in patients with Parkinson’s disease.